DUALE GLP-1/GLP-2-AGONISTEN

European patent · EP3551652 · Deleted

Register entry

Publication number
EP3551652
Application number
EP17832481
Kind
European patent with effect for Switzerland and Liechtenstein
Status
Deleted
Specification
Granted
Filed
Dec 11, 2017
Published
Oct 16, 2019
Granted
Jan 20, 2021
Deleted
Jul 23, 2022
Reason
Annual fee unpaid
IPC classes
C07K 14/605 (2006.01)
A61K 38/26 (2006.01)
Priority
DK PA201600756 09.12.2016
PCT application
PCT/EP2017/082289 11.12.2017
PCT publication
WO2018/104560 14.06.2018
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jul 23, 2022

    Deleted, fee unpaid

    Published in Swissreg on 23.07.2022

  2. Dec 1, 2021

    Change

    Published in Swissreg on 01.12.2021

  3. Jan 20, 2021

    Granted

    Published in Swissreg on 20.01.2021

Parties

Holder

Zealand Pharma A/S

Sydmarken 11, 2860 Søborg, DK

Inventor

EDWARDS, Alistair Vincent Gordon

2860 Soborg, DK

GIEHM, Lise

2860 Soborg, DK

DUE LARSEN, Bjarne

2860 Soborg, DK

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.